- £35.33m
- £15.25m
- $86.68m
- 81
- 77
- 21
- 65
Annual income statement for Nexteq, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 63.8 | 87.1 | 120 | 114 | 86.7 |
| Cost of Revenue | |||||
| Gross Profit | 20.1 | 25.9 | 38.6 | 41.5 | 31.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 65.6 | 82.1 | 111 | 102 | 86.4 |
| Operating Profit | -1.85 | 5.08 | 8.93 | 12.4 | 0.301 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2 | 4.92 | 8.8 | 12.9 | 1.72 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.88 | 4 | 11.1 | 10.9 | 0.311 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.96 | 3.56 | 11 | 10.9 | 0.311 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.96 | 3.56 | 11 | 10.9 | 0.311 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.027 | 0.051 | 0.173 | 0.176 | 0.04 |
| Dividends per Share |